Calcitriol Other names: 1,25-dihydroxycholecalciferol 1,25-dihydroxyvitamin D3

Chemical formula: C₂₇H₄₄O₃  Molecular mass: 416.637 g/mol  PubChem compound: 5280453

Therapeutic indications

Calcitriol is indicated for:

Renal osteodystrophy

Population group: only adults (18 years old or older)

Calcitriol is indicated for the correction of the abnormalities of calcium and phosphate metabolism in patients with renal osteodystrophy.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Post-menopausal osteoporosis

Population group: only adults (18 years old or older)

Calcitriol is also indicated for the treatment of established post-menopausal osteoporosis.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Plaque psoriasis

Population group: only adults (18 - 65 years old)

Calcitriol is indicated in topical treatment of mild to moderately severe plaque psoriasis (psoriasis vulgaris) with up to 35% of body surface area involvement.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Calcitriol is contraindicated in the following cases:

Hypercalcaemia

Hypercalcemia

Metastatic calcification

Metastatic calcification

Vitamin D toxicity

Poisoning by vitamin D

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.